PIII (P3 Health Partners) Beneish M-Score: -2.94 (As of Jul. 06, 2026)


PIII P3 Health Partners Inc PIII
47 GF Score
Price $10.28
GF Value $9.22
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is P3 Health Partners Beneish M-Score?

P3 Health Partners PIII -9.50% 47 Beneish M-Score is -2.94 as of Jul. 06, 2026. GuruFocus rates PIII with a GF Score™ of 47/100 and a GF Value™ of $9.22 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 630 Healthcare Providers & Services companies, P3 Health Partners ranks better than 76.35% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.94 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for P3 Health Partners's Beneish M-Score or its related term are showing as below:

PIII' s Beneish M-Score Range Over the Past 10 Years
Min: -3.28   Med: -2.32   Max: 6.98
Current: -2.94

During the past 8 years, the highest Beneish M-Score of P3 Health Partners was 6.98. The lowest was -3.28. And the median was -2.32.


P3 Health Partners Beneish M-Score Historical Data

* Premium members only.

The historical data trend for P3 Health Partners's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

P3 Health Partners Beneish M-Score Chart

P3 Health Partners Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 3.66 -2.00 -2.94 -3.28

P3 Health Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.95 -3.18 -3.05 -3.28 -2.94

PIII vs EHSI, CDIX, DCGO: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, P3 Health Partners's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


P3 Health Partners Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where P3 Health Partners's Beneish M-Score falls into.


PIII
47GF Score
P3 Health Partners Inc PIII
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

P3 Health Partners Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of P3 Health Partners for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0028+0.528 * 1+0.404 * 0.9882+0.892 * 0.9913+0.115 * 0.9747
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9765+4.679 * -0.062614-0.327 * 1.4827
=-2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $134 Mil.
Revenue was 386.39 + 384.814 + 345.253 + 355.788 = $1,472 Mil.
Gross Profit was 386.39 + 384.814 + 345.253 + 355.788 = $1,472 Mil.
Total Current Assets was $172 Mil.
Total Assets was $674 Mil.
Property, Plant and Equipment(Net PPE) was $3 Mil.
Depreciation, Depletion and Amortization(DDA) was $84 Mil.
Selling, General, & Admin. Expense(SGA) was $108 Mil.
Total Current Liabilities was $525 Mil.
Long-Term Debt & Capital Lease Obligation was $270 Mil.
Net Income was 1.223 + -75.519 + -31.587 + -20.362 = $-126 Mil.
Non Operating Income was 0.572 + 2.749 + -4.7 + 2.585 = $1 Mil.
Cash Flow from Operations was -27.467 + -25.727 + -15.412 + -16.633 = $-85 Mil.
Total Receivables was $135 Mil.
Revenue was 373.225 + 370.686 + 362.124 + 379.157 = $1,485 Mil.
Gross Profit was 373.225 + 370.686 + 362.124 + 379.157 = $1,485 Mil.
Total Current Assets was $191 Mil.
Total Assets was $784 Mil.
Property, Plant and Equipment(Net PPE) was $5 Mil.
Depreciation, Depletion and Amortization(DDA) was $86 Mil.
Selling, General, & Admin. Expense(SGA) was $111 Mil.
Total Current Liabilities was $507 Mil.
Long-Term Debt & Capital Lease Obligation was $117 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(133.954 / 1472.245) / (134.759 / 1485.192)
=0.090986 / 0.090735
=1.0028

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1485.192 / 1485.192) / (1472.245 / 1472.245)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (172.21 + 2.964) / 674.157) / (1 - (191.435 + 5.308) / 783.87)
=0.740158 / 0.749011
=0.9882

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1472.245 / 1485.192
=0.9913

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(85.571 / (85.571 + 5.308)) / (84.185 / (84.185 + 2.964))
=0.941593 / 0.965989
=0.9747

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(107.819 / 1472.245) / (111.384 / 1485.192)
=0.073234 / 0.074996
=0.9765

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((270.399 + 525.485) / 674.157) / ((117.102 + 507.034) / 783.87)
=1.180562 / 0.796224
=1.4827

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-126.245 - 1.206 - -85.239) / 674.157
=-0.062614

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

P3 Health Partners has a M-score of -2.94 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.94 mean?
P3 Health Partners (PIII) has a Beneish M-Score of -2.94 as of Jul. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #149 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 23.7%.
Is P3 Health Partners' Beneish M-Score too high?
P3 Health Partners' current Beneish M-Score is -2.94. Based on the distribution chart, P3 Health Partners ranks #149 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, P3 Health Partners has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' Beneish M-Score compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #149 out of 630 companies for Beneish M-Score. This places P3 Health Partners in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on P3 Health Partners and its competitors. P3 Health Partners's current Beneish M-Score is -2.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.22, compared to a current price of $10.28 — trading 11.5% above its estimated fair value. The current Beneish M-Score is -2.94. P3 Health Partners' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For P3 Health Partners (PIII), the current Beneish M-Score is -2.94 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is P3 Health Partners (PIII) Overvalued in 2026?

Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued. The current stock price of $10.28 is trading 11.5% above its estimated GF Value™ of $9.22. GuruFocus considers P3 Health Partners to be Modestly Overvalued.

Key valuation signals for PIII:

  • Beneish M-Score: -2.94
  • GF Value™: $9.22 vs. price of $10.28 (11.5% above fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


P3 Health Partners Business Description

Address 2370 Corporate Circle, Suite 300, Henderson, NV, USA, 89074
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
47GF Score

Get the complete analysis for PIII

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.28
Price
$9.22
GF Value